Publication | Closed Access

The Efficacy and Safety of High-Dose Mizoribine in ABO-Incompatible Kidney Transplantation Using Anti-CD20 and Anti-CD25 Antibody Without Splenectomy Treatment

UrologyTransplantationKidney TransplantKidney TransplantationImmunosuppressive TherapyHigh-dose MizoribineImmunotherapyMedicineNephrologyGraft Rejection